Research Article Details

Article ID: A25928
PMID: 21318585
Source: Dig Dis Sci
Title: Non-contrasted computed tomography for the accurate measurement of liver steatosis in obese patients.
Abstract: BACKGROUND: Hepatic macrosteatosis (HMS) is prevalent among high BMI patients, but a lack of validation of non-invasive measures of liver fat hampers non-alcoholic liver disease (NAFLD) investigation in general. Recent work suggests BMI adjusted, non-contrasted computed tomography (nc-CT) attenuation data (Hounsfield units) reflects liver fat accumulation in a normal weight population. However, this and other CT-based HMS studies have only approximated macrosteatosis (%) histologically, but have not validated findings with chemical liver triglyceride (TG) concentrations (mg/gram protein). Also, all previous CT based steatosis studies excluded high BMI subjects, whose habitus may affect properties of the scan. We hypothesized that in high BMI patients nc-CT attenuation measurements expressed in Hounsfield units (HU) accurately estimate liver triglyceride concentrations as well as histological macrosteatosis. METHODS: With informed consent, 15 patients underwent nc-CT scan of the abdomen prior to weight loss surgery with intraoperative wedge and core needle liver biopsy. Mean left lobe nc-CT Hounsfield units (CT(L)), liver TG (mg/g Pr), HMS (%), BMI (kg/m(2)), liver-spleen index (CT(L/S)&#160;=&#160;hepatic HU/splenic HU), and liver-spleen difference (CT(L-S)&#160;=&#160;hepatic HU - splenic HU) were a priori outcomes. RESULTS: In 15 patients (11 female) with a BMI of 44.4&#160;&#177;&#160;1.1 (mean&#160;&#177;&#160;SEM), CT(L/S), CT(L-S), and CT(L) measures were significantly associated with liver TG concentrations (r&#160;=&#160;-0.80, P&#160;<&#160;0.001; r&#160;=&#160;-0.80, P&#160;<&#160;0.001; and r&#160;=&#160;-0.71, P&#160;<&#160;0.01, respectively; Table&#160;1). Macrosteatosis (%) and liver triglyceride concentration were positively associated (r&#160;=&#160;0.83; P&#160;<&#160;0.0001). BMI did not correlate strongly to liver triglyceride (r&#160;=&#160;0.44, P&#160;=&#160;NS). CONCLUSION: Estimates of liver fat obtained by nc- CT scans (esp. CT(L/S), CT(L-S)) correlate to chemical measurement of liver triglyceride concentrations, suggesting non-contrasted CT may be a suitable non-invasive "gold standard" for hepatic steatosis quantification in these patients.
DOI: 10.1007/s10620-011-1602-5